Autoimmune disease covers a wide spectrum of unmet medical needs. For example, in Lupus, physicians use a wide variety of medicines to treat the underlying disease, but the remaining unmet medical need is high. In Rheumatoid Arthritis, there are many treatment choices available to patients and, therefore, optimal treatment is individualized.
This complex array of interlinked diseases presents the pharmaceutical industry with various challenges: How best to pursue regulatory approval and commercial reimbursement, how to select the most relevant indication for proof of concept and biosimilar approval pathways, and how to identify appropriate responder populations.
At INC Research/inVentiv Health, we can help sponsors navigate this complex space. We provide strategic counsel and operational excellence—with a clear patient focus—from molecule to commercialization.